• Refine Query
  • Source
  • Publication year
  • to
  • Language
  • 29
  • 26
  • 9
  • 7
  • 5
  • 3
  • 2
  • 1
  • 1
  • Tagged with
  • 95
  • 29
  • 28
  • 22
  • 16
  • 15
  • 15
  • 14
  • 14
  • 14
  • 11
  • 10
  • 9
  • 9
  • 9
  • About
  • The Global ETD Search service is a free service for researchers to find electronic theses and dissertations. This service is provided by the Networked Digital Library of Theses and Dissertations.
    Our metadata is collected from universities around the world. If you manage a university/consortium/country archive and want to be added, details can be found on the NDLTD website.
21

Estrogen Regulates Interferon-gamma (IFN-g) and IFN-g-Inducible iNOS Gene Expression: Implications to Immunity and Autoimmunity

Sahin, Ebru Karpuzoglu 04 May 2005 (has links)
It is now clear that estrogen not only modulates the differentiation and function of reproductive systems, but it also profoundly regulates the immune system of normal and autoimmune individuals. An important mechanism by which estrogen regulates the immune system is by altering the secretion and/or response to cytokines. We hypothesized that estrogen may alter the levels and/or response to IFN-g, a prototype Th1 cytokine, that plays a pivotal role in immunity against intracellular infections and in many autoimmune and inflammatory disorders. We found that estrogen treatment tended to upregulate the secretion of IFN-g protein and mRNA expression from Concanavalin-A (Con-A)-activated splenic lymphocytes. Impressively, we found that splenocytes from estrogen-treated mice when activated with Con-A also resulted in increased release of nitric oxide compared to placebo-treated mice. Furthermore, Con-A-activated splenocytes from estrogen-treated mice also had upregulated iNOS mRNA, iNOS protein, and nitric oxide-regulated COX-2 protein when compared to control mice. Blocking co-stimulatory signals mediated through interactions of CD28 and B7 molecules by using CTLA-4Ig markedly decreased not only IFN-g, but also nitric oxide, thereby implying an important role for CD28/B7 interactions in IFN-g/nitric oxide. Estrogen-induced upregulation of iNOS/nitric oxide is mediated through IFN-g since: (i) Estrogen alone did not upregulate iNOS/nitric oxide in IFN-g knockout mice; (ii) addition of rIFN-g to activated splenocytes from estrogen-treated mice further upregulated nitric oxide levels. We next investigated whether estrogen also upregulated IFN-g-inducing cytokines and select IFN-g-inducing transcription factors. Estrogen treatment resulted in increased mRNA and/or protein expression of IFN-g inducing cytokines and their receptors, including: IL-18, IL-15, IL-27, IL-12Rb2, and IL-18Rb. We also found that T-bet, a critical Th1 transcription factor, and STAT-4 phosphorylation, a key molecule in IL-12 signaling were both increased, while IRF-4, an important player in Th2 differentiation, was diminished in Con-A-activated splenocytes from mice treated with estrogen. Altogether, these studies are the first to demonstrate that estrogen regulates IFN-g-dependent iNOS and describes the potential mechanisms of how estrogen alters IFN-g-inducible genes, IFN-g inducing cytokines, and transcription factors in normal C57BL/6 mice. These studies may have profound implications to many autoimmune and inflammatory disorders, where estrogen is known to regulate the course of these diseases. Since estrogen may promote inflammatory disorders by upregulating pro-inflammatory biomolecules including IFN-g, nitric oxide, and COX-2, these studies may help in the design of therapeutic agents that regulate or block secretion and/or response to these inflammatory molecules. / Ph. D.
22

Expressão do microRNA-27b, eNOS e iNOS nos corpos cavernosos de ratos submetidos ao alcoolismo e diabetes mellitus / Expression of microRNA-27B, eNOS and iNOSin the corpus cavernosumof rats submitted to alcoholism and to diabetes mellitus

Cunha, João Paulo da 25 May 2016 (has links)
A Disfunção Erétil (DE) é um problema de elevada prevalência e mostra-se relacionada com o envelhecimento, diabetes, etilismo, obesidade, dislipidemia, tabagismo e outras doenças que se demonstram relacionadas com disfunção endotelial. O Óxido Nítrico (NO), produto da ação da Óxido Nítrico Sintetase (NOS), foi comprovado ser o mais importante vasodilatador de musculatura lisa associado à ereção. Os microRNAs (miRNA) são moléculas recentemente descobertas, que supõe-se atuar como reguladoras de aproximadamente um terço dos genes humanos. O miRNA-27b está relacionado à função endotelial e angiogênese. O presente trabalho tem por objetivo estudar a expressão da NOS endotelial (eNOS) e indutível iNOS), além do miRNA-27b nos corpos cavernosos e sangue periférico de ratos saudáveis, diabéticos, alcoolizados e com as duas patologias. Foram criados 4 grupos de 12 ratos Winstar: grupo controle(saudáveis) (C), grupo com alcoolismo (A), grupo diabético (D) e grupo com as duas patologias (A+D). Em cada grupo, 6 animais foram estudados pors imunohistoquimica para eNOS e iNOS e 6 animais tiveram a expressão gênica da eNOS, iNOS e miRNA-27b avaliados por qT-PCR nos corpos cavernosos e sangue periférico. Os resultados demonstraram diminuição da expressão do miRNA-27b nos grupos A, D e A+D tanto na amostra tecidual quanto do sangue periférico. A imunohistoquimica mostrou maior expressão de eNOS no grupo D+A e de iNOS nos grupos A e A+D. / Erectile Dysfunction (ED) is a high prevalence problem and appears to be related to aging, diabetes, alcoholism, obesity, dyslipidemia, smoking and other diseases that show related to endothelial dysfunction. Nitric oxide (NO), a product of Nitric Oxide Synthase (NOS), was shown to be the most important vasodilator of smooth muscles associated with the erection. Micro-RNAs (miRNA) are recently discovered molecules which are supposed to act as regulators of approximately one third of human genes. The miRNA-27b is related to endothelial function and angiogenesis. This work aims to study the expression of endothelial and inducible NOS in addition to the miRNA-27b in the corpus cavernosum and peripheral blood of healthy rats, diabetic, alcoholic and with both pathologies. Were created four groups of 12 rats Winstar: control group (healthy) (C), a group with alcoholism (A), diabetic group (D) and group with both disorders (A + D). In each group 6 animals were studied for eNOS and iNOS immunohistochemistry and 6 animals the gene expression of eNOS, iNOS and miRNA-27b evaluated by qT-PCR in the corpus cavernosum and peripheral blood. The results showed increase expression of miRNA-27b in Group A, D and A+D in both the tissue sample and peripheral blood. Immunohistochemistry showed a increase of eNOS expression in group A+D and iNOS high expression in groups A and A+D.
23

Modulação da mecânica do tecido pulmonar periférico e da resposta do  estresse oxidativo pela inibição da arginase e da iNOS em modelo experimental de inflamação crônica pulmonar / Modulation of peripheral lung tissue of mechanical and oxidative stress response by inhibiting arginase and iNOS in an experimental model of chronic pulmonary inflammation

Luciana Ritha de Cassia Rolim Barbosa Aristóteles 18 June 2012 (has links)
Introdução: A importância do parênquima pulmonar na fisiopatologia da asma tem sido recentemente enfatizada, particularmente nos pacientes com asma grave e de difícil controle. O óxido nítrico (NO) é um importante modulador da resposta contrátil, inflamatória e de remodelamento pulmonar que ocorrem na asma. Embora seu papel na modulação em vias aéreas proximais e distais já tenha sido estabelecido, seus efeitos no parênquima pulmonar foram pouco investigados. Objetivos: Avaliar se a inibição da arginase 2, por intermédio do tratamento com N-hydroxy-nor-L-arginine (nor-NOHA), e da iNOS, por intermédio da administração de 1400W, pode modular a resposta constritora de parênquima distal, o estresse oxidativo, a expressão de iNOS, assim como a atividade da arginase, em modelo de inflamação alérgica crônica pulmonar em cobaias. Métodos: Os animais foram expostos a sete inalações com soro fisiológico ou com ovoalbumina em doses crescentes (1~5mg/ml- 4 semanas) e tratados com 1400W (2mg/Kg ip. diariamente) iniciando após a 7ª inalação e nor- NOHA (10M - infusão no banho durante a avaliação da mecânica oscilatória), ou associação de 1400W + nor-NOHA (administrado conforme descrito anteriormente). Setenta e duas horas após a sétima inalação os animais foram anestesiados, exsanguinados e a foi realizada a avaliação da mecânica oscilatória do parênquima pulmonar, sendo obtidos os valores de resistência e elastância tecidual na condição basal e após desafio (0,1% de ovoalbumina). Em seguida, os fragmentos de tecido pulmonar periférico foram fixados em solução de formolaldeído a 4%, por 48 horas. Depois de terminada a fixação, o material foi submetido às técnicas histológicas habituais com parafina, para obtenção de cortes de 4m de espessura. Os cortes foram corados para Hematoxilina e Eosina e utilizando técnica de imunohistoquímica foram avaliados o número de células iNOS positivas, a expressão de PGF2, do fator de transcrição NF-kB e de arginase 2 no septo alveolar, por intermédio de avaliação morfométrica. A expressão de arginase 2, NF-kB e PGF2 nos fragmentos de tecido pulmonar periférico foram avaliados em aumento 400X utilizando o programa Image-Pro Plus 4.5v Image Analysis System e os resultados foram expressos em porcentagem. Em relação ao número de células iNOS positivas nos fragmentos pulmonares, foi utilizada a técnica de contagem de pontos, determinada pelo número de pontos que coincidiam em células positivas em cada campo dividido pelo número de pontos que incidiam no tecido pulmonar, no aumento de 1000x. Foram analisados 10 campos por corte, selecionados de forma randômica. Os resultados foram expressos como células por unidade de área (104m2). Para a avaliação da atividade da arginase 2, foi utilizado o método descrito no kit da BioAssay Systems que utiliza um cromogênio, que forma um complexo corado com uréia, produzido na reação de arginase. A determinação da atividade da arginase 2 envolveu a medida da velocidade de reação, expressa em termos de atividade por miligrama de proteína (U/mg). Resultados: Não houve alteração no percentual de estruturas (vasos, vias aéreas e tecido alveolar) no tecido pulmonar nos quatro grupos experimentais, sendo que mais de 90% de tecido do fragmento pulmonar foi constituído de alvéolos. Os animais que foram expostos à ovoalbumina apresentaram um aumento da resistência e da elastância tecidual (após desafio antigênico), no número de células iNOS positivas, na percentagem de expressão de PGF2, arginase 2 e NF-kB no septo alveolar, assim como da atividade de arginase 2 comparativamente aos grupos controles (p<0,001). O tratamento com nor-NOHA ou 1400W isoladamente em animais expostos à ovoalbumina atenuou a resposta de elastância e resistência teciduais após desafio antigênico (p<0,001), o número de células iNOS positivas (p<0,001), na expressão de PGF2, de arginase 2 e NF-kB no septo alveolar (p<0,001). Porém a atividade da arginase 2 só foi reduzida nos grupos que foram tratados com nor-NOHA e na associação de 1400W e nor-NOHA (p<0,05). A associação de 1400W e nor-NOHA em animais expostos à ovoalbumina potencializou a atenuação da expressão PGF2 no septo alveolar (p<0,001). Conclusões: O presente estudo sugere que, neste modelo experimental de inflamação crônica pulmonar, a inibição da arginase tem papel importante na modulação das repostas constritoras e de estresse oxidativo no parênquima pulmonar distal. A associação da inibição da iNOS à da arginase 2 potencializa o controle da resposta de estresse oxidativo. Estas respostas são, pelo menos em parte, moduladas pela ativação de NF-kB. A inibição destas vias enzimáticas pode representar uma estratégia futura para o tratamento de pacientes com asma grave e de difícil controle / Introduction: The importance of the lung parenchyma in the pathophysiology of asthma has recently been emphasized, particularly in patients with severe asthma and difficult to control. Nitric oxide (NO) is an important modulator of contractile response, lung inflammation and remodeling occurring in asthma. Although its role in the modulation proximal and distal airways tone control has already been established, its effects on the lung parenchyma were rarely investigated. Aims: To evaluate the inhibition of arginase 2, through treatment with N-hydroxy-nor-L-arginine (nor-NOHA) and / or iNOS, through the administration of 1400W, can modulate the constrictor response of distal parenchyma, oxidative stress, the expression of iNOS and the activity of arginase, in a model of chronic allergic lung inflammation in guinea pigs. Methods: The seven animals were exposed to inhaled saline or ovalbumin with increasing doses (1~5mg/ml-4 weeks) and treated with 1400W (2mg/kg ip daily) beginning after the 7th inhalation and nor-NOHA (10M - infusion in the bath during the evaluation of mechanical oscillation), or combination of 1400W + nor- NOHA (administered as formerly). Seventy-two hours after the seventh inhalation the animals were anesthetized, and exsanguinated and it was performed evaluation was made of oscillatory mechanics of lung parenchyma, and obtained the values of tissue resistance and elastance at baseline and after challenge (0.1% ovalbumin). Then the peripheral lung tissue fragments were fixed in formolaldeíde 4% for 48 hours. After completion of fixation, the material was subjected to routine histological techniques with paraffin to obtain sections of 4m thickness. The sections were stained with Hematoxylin and Eosin and by using immunohistochemical technique, we assessed the number of iNOS positive cells and expression of PGF2, of the transcription factor NF-kB and arginase 2 in the alveolar septum, through morphometric analysis. The expression of arginase 2, NF-kB and PGF2 in peripheral lung tissue fragments were evaluated at 400X increase by Image - Pro Plus Image Analysis System 4.5v and the results were obtained as a ratio between the amount of expression of arginase 2, NF-kB and PGF2 and are expressed as percentage. Regarding the content of iNOS in lung fragments, we used the technique of counting points, determined by the number of points coinciding in the positive cells in each field divided by the number of points that focused on lung tissue, using the increase of 1000x. Were increase of 10 fields analyzed per section, selected randomly. The results were expressed as cells per unit area (104m2). To assess the activity of arginase 2 we used the method bioassay described in the kit Systems using a chromogen which forms a colored complex with urea produced in the reaction of arginase. The determination of the activity of arginase 2 involved the measurement of reaction rate, expressed in terms of activity per milligram of protein (U/mg). Results: There were no changes in the percentages of structures (vessels, airways and alveolar tissue) lung tissue in four experimental groups, with more than 90% of the tissue fragment consisted of pulmonary alveoli. The animals that were exposed to ovalbumin, showed an increase in tissue resistance and elastance after antigen challenge, the number of iNOS positive cells, the of expression of PGF2, of NF-kB and arginase 2 in the alveolar septum well as in the activity of arginase 2, compared to control groups (p <0.001). The treatment with nor-NOHA or 1400W alone in animals exposed to ovalbumin attenuated the tissue elastance and resistance after antigenic challenge (p <0.001), the number of iNOS positive cells (p <0.001), the expression of PGF2, arginase 2 and NFkB in the alveolar septum (p<0.001). However the activity of arginase 2 was reduced in only in the groups that were treated with nor-NOHA and the association of 1400W and nor-NOHA (p <0.05). The combination of 1400W and nor-NOHA, in animals exposed to ovalbumin enhanced the attenuation of the expression of PGF2 in the alveolar septum (p <0.001). Conclusions: The present study suggests that in this experimental model of chronic pulmonary inflammation, inhibition of arginase 2 plays an important role in the modulation of constrictor responses and oxidative stress in the distal lung parenchyma. The association of iNOS inhibition to the arginase 2 enhances the control of oxidative stress response. These responses are, at least in part, modulated by the activation of NF-kB. The inhibition of these enzyme pathways may represent a future strategy for the treatment of patients with severe asthma and difficult to control
24

Expressão do microRNA-27b, eNOS e iNOS nos corpos cavernosos de ratos submetidos ao alcoolismo e diabetes mellitus / Expression of microRNA-27B, eNOS and iNOSin the corpus cavernosumof rats submitted to alcoholism and to diabetes mellitus

João Paulo da Cunha 25 May 2016 (has links)
A Disfunção Erétil (DE) é um problema de elevada prevalência e mostra-se relacionada com o envelhecimento, diabetes, etilismo, obesidade, dislipidemia, tabagismo e outras doenças que se demonstram relacionadas com disfunção endotelial. O Óxido Nítrico (NO), produto da ação da Óxido Nítrico Sintetase (NOS), foi comprovado ser o mais importante vasodilatador de musculatura lisa associado à ereção. Os microRNAs (miRNA) são moléculas recentemente descobertas, que supõe-se atuar como reguladoras de aproximadamente um terço dos genes humanos. O miRNA-27b está relacionado à função endotelial e angiogênese. O presente trabalho tem por objetivo estudar a expressão da NOS endotelial (eNOS) e indutível iNOS), além do miRNA-27b nos corpos cavernosos e sangue periférico de ratos saudáveis, diabéticos, alcoolizados e com as duas patologias. Foram criados 4 grupos de 12 ratos Winstar: grupo controle(saudáveis) (C), grupo com alcoolismo (A), grupo diabético (D) e grupo com as duas patologias (A+D). Em cada grupo, 6 animais foram estudados pors imunohistoquimica para eNOS e iNOS e 6 animais tiveram a expressão gênica da eNOS, iNOS e miRNA-27b avaliados por qT-PCR nos corpos cavernosos e sangue periférico. Os resultados demonstraram diminuição da expressão do miRNA-27b nos grupos A, D e A+D tanto na amostra tecidual quanto do sangue periférico. A imunohistoquimica mostrou maior expressão de eNOS no grupo D+A e de iNOS nos grupos A e A+D. / Erectile Dysfunction (ED) is a high prevalence problem and appears to be related to aging, diabetes, alcoholism, obesity, dyslipidemia, smoking and other diseases that show related to endothelial dysfunction. Nitric oxide (NO), a product of Nitric Oxide Synthase (NOS), was shown to be the most important vasodilator of smooth muscles associated with the erection. Micro-RNAs (miRNA) are recently discovered molecules which are supposed to act as regulators of approximately one third of human genes. The miRNA-27b is related to endothelial function and angiogenesis. This work aims to study the expression of endothelial and inducible NOS in addition to the miRNA-27b in the corpus cavernosum and peripheral blood of healthy rats, diabetic, alcoholic and with both pathologies. Were created four groups of 12 rats Winstar: control group (healthy) (C), a group with alcoholism (A), diabetic group (D) and group with both disorders (A + D). In each group 6 animals were studied for eNOS and iNOS immunohistochemistry and 6 animals the gene expression of eNOS, iNOS and miRNA-27b evaluated by qT-PCR in the corpus cavernosum and peripheral blood. The results showed increase expression of miRNA-27b in Group A, D and A+D in both the tissue sample and peripheral blood. Immunohistochemistry showed a increase of eNOS expression in group A+D and iNOS high expression in groups A and A+D.
25

Modulação da mecânica do tecido pulmonar periférico e da resposta do  estresse oxidativo pela inibição da arginase e da iNOS em modelo experimental de inflamação crônica pulmonar / Modulation of peripheral lung tissue of mechanical and oxidative stress response by inhibiting arginase and iNOS in an experimental model of chronic pulmonary inflammation

Aristóteles, Luciana Ritha de Cassia Rolim Barbosa 18 June 2012 (has links)
Introdução: A importância do parênquima pulmonar na fisiopatologia da asma tem sido recentemente enfatizada, particularmente nos pacientes com asma grave e de difícil controle. O óxido nítrico (NO) é um importante modulador da resposta contrátil, inflamatória e de remodelamento pulmonar que ocorrem na asma. Embora seu papel na modulação em vias aéreas proximais e distais já tenha sido estabelecido, seus efeitos no parênquima pulmonar foram pouco investigados. Objetivos: Avaliar se a inibição da arginase 2, por intermédio do tratamento com N-hydroxy-nor-L-arginine (nor-NOHA), e da iNOS, por intermédio da administração de 1400W, pode modular a resposta constritora de parênquima distal, o estresse oxidativo, a expressão de iNOS, assim como a atividade da arginase, em modelo de inflamação alérgica crônica pulmonar em cobaias. Métodos: Os animais foram expostos a sete inalações com soro fisiológico ou com ovoalbumina em doses crescentes (1~5mg/ml- 4 semanas) e tratados com 1400W (2mg/Kg ip. diariamente) iniciando após a 7ª inalação e nor- NOHA (10M - infusão no banho durante a avaliação da mecânica oscilatória), ou associação de 1400W + nor-NOHA (administrado conforme descrito anteriormente). Setenta e duas horas após a sétima inalação os animais foram anestesiados, exsanguinados e a foi realizada a avaliação da mecânica oscilatória do parênquima pulmonar, sendo obtidos os valores de resistência e elastância tecidual na condição basal e após desafio (0,1% de ovoalbumina). Em seguida, os fragmentos de tecido pulmonar periférico foram fixados em solução de formolaldeído a 4%, por 48 horas. Depois de terminada a fixação, o material foi submetido às técnicas histológicas habituais com parafina, para obtenção de cortes de 4m de espessura. Os cortes foram corados para Hematoxilina e Eosina e utilizando técnica de imunohistoquímica foram avaliados o número de células iNOS positivas, a expressão de PGF2, do fator de transcrição NF-kB e de arginase 2 no septo alveolar, por intermédio de avaliação morfométrica. A expressão de arginase 2, NF-kB e PGF2 nos fragmentos de tecido pulmonar periférico foram avaliados em aumento 400X utilizando o programa Image-Pro Plus 4.5v Image Analysis System e os resultados foram expressos em porcentagem. Em relação ao número de células iNOS positivas nos fragmentos pulmonares, foi utilizada a técnica de contagem de pontos, determinada pelo número de pontos que coincidiam em células positivas em cada campo dividido pelo número de pontos que incidiam no tecido pulmonar, no aumento de 1000x. Foram analisados 10 campos por corte, selecionados de forma randômica. Os resultados foram expressos como células por unidade de área (104m2). Para a avaliação da atividade da arginase 2, foi utilizado o método descrito no kit da BioAssay Systems que utiliza um cromogênio, que forma um complexo corado com uréia, produzido na reação de arginase. A determinação da atividade da arginase 2 envolveu a medida da velocidade de reação, expressa em termos de atividade por miligrama de proteína (U/mg). Resultados: Não houve alteração no percentual de estruturas (vasos, vias aéreas e tecido alveolar) no tecido pulmonar nos quatro grupos experimentais, sendo que mais de 90% de tecido do fragmento pulmonar foi constituído de alvéolos. Os animais que foram expostos à ovoalbumina apresentaram um aumento da resistência e da elastância tecidual (após desafio antigênico), no número de células iNOS positivas, na percentagem de expressão de PGF2, arginase 2 e NF-kB no septo alveolar, assim como da atividade de arginase 2 comparativamente aos grupos controles (p<0,001). O tratamento com nor-NOHA ou 1400W isoladamente em animais expostos à ovoalbumina atenuou a resposta de elastância e resistência teciduais após desafio antigênico (p<0,001), o número de células iNOS positivas (p<0,001), na expressão de PGF2, de arginase 2 e NF-kB no septo alveolar (p<0,001). Porém a atividade da arginase 2 só foi reduzida nos grupos que foram tratados com nor-NOHA e na associação de 1400W e nor-NOHA (p<0,05). A associação de 1400W e nor-NOHA em animais expostos à ovoalbumina potencializou a atenuação da expressão PGF2 no septo alveolar (p<0,001). Conclusões: O presente estudo sugere que, neste modelo experimental de inflamação crônica pulmonar, a inibição da arginase tem papel importante na modulação das repostas constritoras e de estresse oxidativo no parênquima pulmonar distal. A associação da inibição da iNOS à da arginase 2 potencializa o controle da resposta de estresse oxidativo. Estas respostas são, pelo menos em parte, moduladas pela ativação de NF-kB. A inibição destas vias enzimáticas pode representar uma estratégia futura para o tratamento de pacientes com asma grave e de difícil controle / Introduction: The importance of the lung parenchyma in the pathophysiology of asthma has recently been emphasized, particularly in patients with severe asthma and difficult to control. Nitric oxide (NO) is an important modulator of contractile response, lung inflammation and remodeling occurring in asthma. Although its role in the modulation proximal and distal airways tone control has already been established, its effects on the lung parenchyma were rarely investigated. Aims: To evaluate the inhibition of arginase 2, through treatment with N-hydroxy-nor-L-arginine (nor-NOHA) and / or iNOS, through the administration of 1400W, can modulate the constrictor response of distal parenchyma, oxidative stress, the expression of iNOS and the activity of arginase, in a model of chronic allergic lung inflammation in guinea pigs. Methods: The seven animals were exposed to inhaled saline or ovalbumin with increasing doses (1~5mg/ml-4 weeks) and treated with 1400W (2mg/kg ip daily) beginning after the 7th inhalation and nor-NOHA (10M - infusion in the bath during the evaluation of mechanical oscillation), or combination of 1400W + nor- NOHA (administered as formerly). Seventy-two hours after the seventh inhalation the animals were anesthetized, and exsanguinated and it was performed evaluation was made of oscillatory mechanics of lung parenchyma, and obtained the values of tissue resistance and elastance at baseline and after challenge (0.1% ovalbumin). Then the peripheral lung tissue fragments were fixed in formolaldeíde 4% for 48 hours. After completion of fixation, the material was subjected to routine histological techniques with paraffin to obtain sections of 4m thickness. The sections were stained with Hematoxylin and Eosin and by using immunohistochemical technique, we assessed the number of iNOS positive cells and expression of PGF2, of the transcription factor NF-kB and arginase 2 in the alveolar septum, through morphometric analysis. The expression of arginase 2, NF-kB and PGF2 in peripheral lung tissue fragments were evaluated at 400X increase by Image - Pro Plus Image Analysis System 4.5v and the results were obtained as a ratio between the amount of expression of arginase 2, NF-kB and PGF2 and are expressed as percentage. Regarding the content of iNOS in lung fragments, we used the technique of counting points, determined by the number of points coinciding in the positive cells in each field divided by the number of points that focused on lung tissue, using the increase of 1000x. Were increase of 10 fields analyzed per section, selected randomly. The results were expressed as cells per unit area (104m2). To assess the activity of arginase 2 we used the method bioassay described in the kit Systems using a chromogen which forms a colored complex with urea produced in the reaction of arginase. The determination of the activity of arginase 2 involved the measurement of reaction rate, expressed in terms of activity per milligram of protein (U/mg). Results: There were no changes in the percentages of structures (vessels, airways and alveolar tissue) lung tissue in four experimental groups, with more than 90% of the tissue fragment consisted of pulmonary alveoli. The animals that were exposed to ovalbumin, showed an increase in tissue resistance and elastance after antigen challenge, the number of iNOS positive cells, the of expression of PGF2, of NF-kB and arginase 2 in the alveolar septum well as in the activity of arginase 2, compared to control groups (p <0.001). The treatment with nor-NOHA or 1400W alone in animals exposed to ovalbumin attenuated the tissue elastance and resistance after antigenic challenge (p <0.001), the number of iNOS positive cells (p <0.001), the expression of PGF2, arginase 2 and NFkB in the alveolar septum (p<0.001). However the activity of arginase 2 was reduced in only in the groups that were treated with nor-NOHA and the association of 1400W and nor-NOHA (p <0.05). The combination of 1400W and nor-NOHA, in animals exposed to ovalbumin enhanced the attenuation of the expression of PGF2 in the alveolar septum (p <0.001). Conclusions: The present study suggests that in this experimental model of chronic pulmonary inflammation, inhibition of arginase 2 plays an important role in the modulation of constrictor responses and oxidative stress in the distal lung parenchyma. The association of iNOS inhibition to the arginase 2 enhances the control of oxidative stress response. These responses are, at least in part, modulated by the activation of NF-kB. The inhibition of these enzyme pathways may represent a future strategy for the treatment of patients with severe asthma and difficult to control
26

Efeitos dos tratamentos com glicocorticóides, com antagonista do receptor do cisteinil-leucotrieno D4 e com o inibidor específico da iNOS na resposta inflamatória e de remodelamento no tecido pulmonar periférico em mode / Efects of treatment with glucocorticoids, associated with cisteinil-leukotriene D4 antagonist and specific iNOS inhibitor in inflammatory response and remodeling in pulmonary tissue of chronic pulmonary inflammation model

Souza, Flavia Castro Ribas de 09 March 2012 (has links)
Introdução: Estima-se que 10% dos doentes com asma t€m sintomas e limita‚es importantes, como exacerba‚es freqƒentes ou redu„o persistente da fun„o respirat…ria As altera‚es do par€nquima pulmonar distal tem sido recentemente abordadas na fisiopatologia da asma. Apesar do uso de corticoster…ides, pacientes com asma refrat†ria t€m mais estresse oxidativo, assim como apresentam ativaao da iNOS. Al‡m disso, muitos dos dispositivos utilizados para administra„o de ester…ides inalat…rios geram partˆculas que n„o chegam efetivamente ‰s vias a‡reas distais e ao par€nquima pulmonar. Objetivos: Avaliamos os efeitos do tratamento com montelucaste ou dexametasona tratamentos associados ou n„o a um inibidor especˆfio da iNOS (1400W) na resposta eosinofˆlica, remodelamento da matriz extracelular, estresse oxidativo, conteŠdo de actina, c‡lulas positivas para IL4, IL5, MMP9, TIMP1, IFN, TGF do par€nquima em cobaias com inflama„o crnica pulmonar. Métodos: As cobaias foram inaladas com ovalbumina (grupo OVA) 2X/semana por 4semanas. Ap…s a 4Ž inala„o, as cobaias foram tratadas diariamente com montelucaste (grupo OVAM 10mg/Kg/PO/dia) ou dexametasona (grupo OVAD 5mg/Kg/IP/dia). O inibidor da iNOS, 1400W (grupo OVAW 1mg/kg/dia) foi administrado intraperitonealmente nos Šltimos 4 dias (OVAW, OVADW e grupos OVAMW). Ap…s 72 horas da 7Ž inala„o, as cobaias foram anestesiadas, e os fragmentos de tecido pulmonar distal foram submetidos ‰ avalia„o histopatol…gica. Resultados: Houve um aumento no infiltrado eosinofˆlco, nas c‡lulas positivas para IL4, IL5, TIMP1, MMP9, iNOS, IFN TGF, conteŠdo de actina, isoprostano PGF2 alfa, fibras col†genas e el†sticas nos animais OVA em compara„o com animais SAL (p<0,05). Houve uma diminui„o no nŠmero de eosin…filos, c‡lulas positivas para IL4, IL5, MMP9, TIMP1, IFN, TGF, conteŠdo de actina, col†geno e isoprostano PGF2 alfa em todos os grupos tratados em compara„o com animais OVA (p<0,05). O conteŠdo de fibras el†sticas foram reduzidas somente nos grupos OVAMW, OVADW e OVAW em compara„o com animais OVA (p<0,05). A associa„o de 1400W e o tratamento com montelucaste (grupo OVAMW) potencializou a redu„o do conteŠdo de actina, fibras el†sticas, isoprostano PGF2 alfa de c‡lulas positivas para IL4, IL5, TIMP1, IFN TGF e iNOS em rela„o ao grupo montelucaste (OVAM) (p<0,05). Os tratamentos com 1400W e dexametasona (grupo OVADW) contribuˆram para uma maior redu„o do conteŠdo das fibras el†sticas, actina e isoprostanoPGF2 alfa e o nŠmero de c‡lulas positivas para IL4, IL5, IFN e TIMP1 em rela„o ao grupo dexametasona (OVAD) (p<0,05). Conclusões: O tratamento com corticoster…ides associados ‰ inibi„o da iNOS contribuiu para uma maior redu„o da remodela„o da matriz extracelular, diminuiu o estresse oxidativo, e tamb‡m foi eficiente para atenuar a resposta inflamat…ria Th2 no par€nquima pulmonar distal. Por outro lado, o tratamento com montelucaste associado à inibição da iNOS mostrou uma maior eficácia para reduzir o teor de fibras elásticas, a ativação do estresse oxidativo, conteúdo de actina e expressão das células positivas para IL4, IL5 no parênquima pulmonar distal. Estas associações podem representar futuras ferramentas farmacológicas para o controle das alterações histopatológicas pulmonares distais induzidas pela inflamação crônica / Introduction: It is estimated that 10% of asthma patients have symptoms and important limitations such as frequent exacerbations or persistent reduction of resiratory function, despite the use of corticosteroids. The alterations of distal lung parenchyma have been recently evaluated on asthma pathophysiology, particulary in patients with refractory asthma and difficcult to control. These patients have increased oxidative stress responses, mainly with significant activation of iNOS. Aims: We evaluated the effects of montelukast or dexamethasone treatments associated or not to an iNOS inhibitor (1400W) on eosinophilic response, extracellular matrix remodeling, oxidative stress, actin content, IL4, IL5, MMP9, TIMP1, IFN gama, TGF beta positive cells of distal lung parenchyma in guinea pigs with chronic alergic inflammation. Methods: Guinea Pigs were inhaled with ovalbumin (OVA group) twice a week for four weeks. After 4th inhalation, GP were treated with montelukast (OVAM group-10mg/Kg/PO/day) or dexamethasone (OVAD group-5mg/Kg/IP/day). The treatment with iNOS inhibitor 1400W (OVAW group-1mg/kg/day) was given daily in the last 4 days (OVAW, OVADW and OVAMW groups). After 72 hours of 7th inhalation, GP were anesthetized, lung strips were retired and submitted to histopathological evaluation. Results: There was an increase in eosinophilic infiltrate, in the number of positive cells for IL4, IL5, TIMP1, MMP9, iNOS, IFN gama TGF beta, actin, isoprostane PGF2 alpha, elastic and collagen fiber contents in OVA animals comparing to SAL group (p<0,05). There was a decrease in the number of eosinophils, IL4, IL5, MMP9, TIMP1, IFN gama, TGF beta positive cells, collagen, actin and isoprostane PGF2 alpha content in all treated groups compared to OVA animals (p<0.05), but the treatment with montelukast did not reduce the positive cells for IFN gama, compared to OVA (p>0.05). Elastic fiber content were reduced only in OVAMW, OVADW and OVAW groups compared to OVA animals (p<0.05). The association of 1400W and montelukast treatments potentiated the reduction of actin, elastic fibres and isoprostane PGF2 alpha contents and the number of IL4, IL5, TIMP1, IFN gama, TGF beta and iNOS positive cells compared to montelukast group (p<0.05). The treatments with 1400W and dexamethasone contributed to a greater reduction of elastic fibers, actin and isoprostane PGF2 alpha contents and the number of IL4, IL5, IFNgama and TIMP1 positive cells compared to dexamethasone group (p<0.05). Conclusions: Corticosteroid treatment associated to iNOS inhibition contributes to a greater reduction of extracellular matrix remodeling, decreases the oxidative stress, and also is efficient to attenuate the Th2 inflammatory response in distal lung parenchyma. On the other hand, montelukast treatment associated to iNOS inhibition showed a higher efficacy to reduce elastic fibres content, oxidative stress activation, actin content and IL4 and IL5 expression in distal lung parenchyma. These associations may represent future pharmacological tools for controlling distal pulmonary histopathological alterations induced by chronic inflammation
27

Efeitos dos tratamentos com glicocorticóides, com antagonista do receptor do cisteinil-leucotrieno D4 e com o inibidor específico da iNOS na resposta inflamatória e de remodelamento no tecido pulmonar periférico em mode / Efects of treatment with glucocorticoids, associated with cisteinil-leukotriene D4 antagonist and specific iNOS inhibitor in inflammatory response and remodeling in pulmonary tissue of chronic pulmonary inflammation model

Flavia Castro Ribas de Souza 09 March 2012 (has links)
Introdução: Estima-se que 10% dos doentes com asma t€m sintomas e limita‚es importantes, como exacerba‚es freqƒentes ou redu„o persistente da fun„o respirat…ria As altera‚es do par€nquima pulmonar distal tem sido recentemente abordadas na fisiopatologia da asma. Apesar do uso de corticoster…ides, pacientes com asma refrat†ria t€m mais estresse oxidativo, assim como apresentam ativaao da iNOS. Al‡m disso, muitos dos dispositivos utilizados para administra„o de ester…ides inalat…rios geram partˆculas que n„o chegam efetivamente ‰s vias a‡reas distais e ao par€nquima pulmonar. Objetivos: Avaliamos os efeitos do tratamento com montelucaste ou dexametasona tratamentos associados ou n„o a um inibidor especˆfio da iNOS (1400W) na resposta eosinofˆlica, remodelamento da matriz extracelular, estresse oxidativo, conteŠdo de actina, c‡lulas positivas para IL4, IL5, MMP9, TIMP1, IFN, TGF do par€nquima em cobaias com inflama„o crnica pulmonar. Métodos: As cobaias foram inaladas com ovalbumina (grupo OVA) 2X/semana por 4semanas. Ap…s a 4Ž inala„o, as cobaias foram tratadas diariamente com montelucaste (grupo OVAM 10mg/Kg/PO/dia) ou dexametasona (grupo OVAD 5mg/Kg/IP/dia). O inibidor da iNOS, 1400W (grupo OVAW 1mg/kg/dia) foi administrado intraperitonealmente nos Šltimos 4 dias (OVAW, OVADW e grupos OVAMW). Ap…s 72 horas da 7Ž inala„o, as cobaias foram anestesiadas, e os fragmentos de tecido pulmonar distal foram submetidos ‰ avalia„o histopatol…gica. Resultados: Houve um aumento no infiltrado eosinofˆlco, nas c‡lulas positivas para IL4, IL5, TIMP1, MMP9, iNOS, IFN TGF, conteŠdo de actina, isoprostano PGF2 alfa, fibras col†genas e el†sticas nos animais OVA em compara„o com animais SAL (p<0,05). Houve uma diminui„o no nŠmero de eosin…filos, c‡lulas positivas para IL4, IL5, MMP9, TIMP1, IFN, TGF, conteŠdo de actina, col†geno e isoprostano PGF2 alfa em todos os grupos tratados em compara„o com animais OVA (p<0,05). O conteŠdo de fibras el†sticas foram reduzidas somente nos grupos OVAMW, OVADW e OVAW em compara„o com animais OVA (p<0,05). A associa„o de 1400W e o tratamento com montelucaste (grupo OVAMW) potencializou a redu„o do conteŠdo de actina, fibras el†sticas, isoprostano PGF2 alfa de c‡lulas positivas para IL4, IL5, TIMP1, IFN TGF e iNOS em rela„o ao grupo montelucaste (OVAM) (p<0,05). Os tratamentos com 1400W e dexametasona (grupo OVADW) contribuˆram para uma maior redu„o do conteŠdo das fibras el†sticas, actina e isoprostanoPGF2 alfa e o nŠmero de c‡lulas positivas para IL4, IL5, IFN e TIMP1 em rela„o ao grupo dexametasona (OVAD) (p<0,05). Conclusões: O tratamento com corticoster…ides associados ‰ inibi„o da iNOS contribuiu para uma maior redu„o da remodela„o da matriz extracelular, diminuiu o estresse oxidativo, e tamb‡m foi eficiente para atenuar a resposta inflamat…ria Th2 no par€nquima pulmonar distal. Por outro lado, o tratamento com montelucaste associado à inibição da iNOS mostrou uma maior eficácia para reduzir o teor de fibras elásticas, a ativação do estresse oxidativo, conteúdo de actina e expressão das células positivas para IL4, IL5 no parênquima pulmonar distal. Estas associações podem representar futuras ferramentas farmacológicas para o controle das alterações histopatológicas pulmonares distais induzidas pela inflamação crônica / Introduction: It is estimated that 10% of asthma patients have symptoms and important limitations such as frequent exacerbations or persistent reduction of resiratory function, despite the use of corticosteroids. The alterations of distal lung parenchyma have been recently evaluated on asthma pathophysiology, particulary in patients with refractory asthma and difficcult to control. These patients have increased oxidative stress responses, mainly with significant activation of iNOS. Aims: We evaluated the effects of montelukast or dexamethasone treatments associated or not to an iNOS inhibitor (1400W) on eosinophilic response, extracellular matrix remodeling, oxidative stress, actin content, IL4, IL5, MMP9, TIMP1, IFN gama, TGF beta positive cells of distal lung parenchyma in guinea pigs with chronic alergic inflammation. Methods: Guinea Pigs were inhaled with ovalbumin (OVA group) twice a week for four weeks. After 4th inhalation, GP were treated with montelukast (OVAM group-10mg/Kg/PO/day) or dexamethasone (OVAD group-5mg/Kg/IP/day). The treatment with iNOS inhibitor 1400W (OVAW group-1mg/kg/day) was given daily in the last 4 days (OVAW, OVADW and OVAMW groups). After 72 hours of 7th inhalation, GP were anesthetized, lung strips were retired and submitted to histopathological evaluation. Results: There was an increase in eosinophilic infiltrate, in the number of positive cells for IL4, IL5, TIMP1, MMP9, iNOS, IFN gama TGF beta, actin, isoprostane PGF2 alpha, elastic and collagen fiber contents in OVA animals comparing to SAL group (p<0,05). There was a decrease in the number of eosinophils, IL4, IL5, MMP9, TIMP1, IFN gama, TGF beta positive cells, collagen, actin and isoprostane PGF2 alpha content in all treated groups compared to OVA animals (p<0.05), but the treatment with montelukast did not reduce the positive cells for IFN gama, compared to OVA (p>0.05). Elastic fiber content were reduced only in OVAMW, OVADW and OVAW groups compared to OVA animals (p<0.05). The association of 1400W and montelukast treatments potentiated the reduction of actin, elastic fibres and isoprostane PGF2 alpha contents and the number of IL4, IL5, TIMP1, IFN gama, TGF beta and iNOS positive cells compared to montelukast group (p<0.05). The treatments with 1400W and dexamethasone contributed to a greater reduction of elastic fibers, actin and isoprostane PGF2 alpha contents and the number of IL4, IL5, IFNgama and TIMP1 positive cells compared to dexamethasone group (p<0.05). Conclusions: Corticosteroid treatment associated to iNOS inhibition contributes to a greater reduction of extracellular matrix remodeling, decreases the oxidative stress, and also is efficient to attenuate the Th2 inflammatory response in distal lung parenchyma. On the other hand, montelukast treatment associated to iNOS inhibition showed a higher efficacy to reduce elastic fibres content, oxidative stress activation, actin content and IL4 and IL5 expression in distal lung parenchyma. These associations may represent future pharmacological tools for controlling distal pulmonary histopathological alterations induced by chronic inflammation
28

Charakterisierung von B-Zellen und Plasmazellen im Kontext einer chronischen Helicobacter pylori-Infektion

Neumann, Laura 10 July 2018 (has links)
Helicobacter pylori ist ein humanpathogenes Bakterium, das den Magen kolonisiert und dadurch eine Immunantwort des Wirts induziert. Statt eine vollständige Eradikation von H. pylori durch die Immunreaktion zu erreichen, kommt es normalerweise zu einer lebenslangen Persistenz des Bakteriums und einer chronischen Infektion. Interessanterweise kommt es infolge einer Infektion zu einer Hochregulation der induzierbaren Stickstoffmonoxid-Synthase (iNOS), aber die zellulären Quellen und zugrundeliegenden Mechanismen von iNOS sind noch nicht vollständig verstanden. Der iNOS-abhängigen Produktion von Stickstoffmonoxid (NO) können sowohl antimikrobielle als auch pathologische Eigenschaften zugeschrieben werden. Daher wurden in der vorliegenden Arbeit iNOS-exprimierende Plasmazellen (PZ) aus der Magenmukosa H. pylori-infizierter Patienten isoliert und phänotypisch, vor allem mittels Durchflusszytometrie und molekularbiologisch hinsichtlich ihres Immunglobulin-Repertoires untersucht. Es wurde erstmals gezeigt, dass mukosale IgA-sezernierende PZ eine der wesentlichen iNOS+ Zelltypen während einer H. pylori-Infektion im Menschen darstellen und zusätzlich wurde ihre intrazelluläre NO-Produktion nachgewiesen. Da iNOS+ PZ in weiteren gastrointestinalen Infektionskrankheiten fehlten, scheint dies kein genereller Phänotyp von PZ der mukosalen Immunabwehr zu sein. Die Analyse der intrazellulären Zytokin-Expression der mukosalen B-Zellpopulationen in H. pylori-Patienten ergab eine Ko-Expression von IFN-γ und TNF-α in iNOS+ memory B-Zellen und eine TNF-α-Expression in iNOS+ PZ, aber nicht in den iNOS− Zellen. Die molekularbiologische Charakterisierung des Immunglobulin-Repertoires von iNOS+ und iNOS− PZ hinsichtlich der VHDJH-Regionen ergab keinen signifikanten Unterschied hinsichtlich der Isotyp-Verteilungen, der Nutzung der VH- und JH-Segmente, CDRH3-Längen sowie somatischen Mutationen und alle Antikörper zeigten typische Charakteristika einer T-zellabhängigen Affinitätsreifung. / Helicobacter pylori is a human-pathogenic bacterium that colonizes the stomach and thereby initiates host immune response. Instead of a complete eradication of H. pylori by the induced immune response, a lifelong bacterial persistence leads to chronic infections. Interestingly, up-regulation of inducible nitric oxide synthase (iNOS) has been observed in gastric mucosal tissue during the course of H. pylori infection in humans, however the cellular sources and underlying mechanisms of iNOS induction are not fully understood. iNOS-dependent production of nitric oxide (NO) is one of the factors commonly linked to both, anti-microbial immunity and pathology. Therefore, in this thesis iNOS-expressing plasma cells (PCs) in the stomach mucosa of H. pylori-infected patients were isolated and phenotypically analyzed by flow cytometry, as well as screened using molecular techniques regarding their immunoglobuline (Ig) repertoires. For the first time, we identified mucosal IgA-producing PCs as a major iNOS+ cell population during H. pylori infection in humans, and additionally confirmed their intracellular nitric oxide production. Since iNOS+ PCs were not detectable in other gastrointestinal infectious diseases, this reaction does not seem to be a general feature of mucosal PCs under conditions of infection. Additionally, intracellular cytokine expression analyses of mucosal B-lineage cells isolated from H. pylori patients revealed a co-expression of IFN-γ and TNF-α in iNOS+ memory B cells and the expression of TNF-α in iNOS+ PCs, but not in iNOS− cells. Molecular analysis of the Ig repertoire of iNOS+ and iNOS− PCs of the VHDJH regions revealed no significant differences regarding the Ig isotype composition, VH and JH gene family usage, CDRH3 length, and frequency of somatic mutations and all antibodies were characterized by typical properties of T cell-dependent affinity maturation.
29

Die Rolle von IFN Gamma in der Immunregulation

Eulenburg, Katharina zu 14 March 2007 (has links)
In der vorliegenden Arbeit wurde die Rolle des Zytokins IFN-gamma in einer Th1-vermittelten Entzündungsreaktion untersucht. Ausgangspunkt war die Beobachtung, dass die Blockade des als proinflammatorisch beschriebenen Zytokins IFN-gamma zu einer chronischen Entzündung führte. Ziel war also das Erkennen und Verstehen der Regulationsmechanismen, sowie die Identifizierung beteiligter Zelltypen und beteiligter Moleküle. Mit Hilfe von Knochenmarkschimären konnte gezeigt werden, dass die Zelle, die von Th1-Zellen sekrektiertes IFN-gamma erkannte, haematopoietischen Ursprungs war. Zum weiteren Verständnis der Regulationsmechanismen wurden Tiere unter IFN-gamma-Blockade mit Tieren, die einen Kontrollantikörper erhielten, verglichen. Mittels Immunhistochemie konnte in Kontrolltieren eine starke Expression von iNOS am Ort der Entzündung nachgewiesen werden, während in Tieren, in denen IFN-gamma blockiert wurde, keine iNOS Expression nachzuweisen war. Mit Hilfe von iNOS-defizienten Mäusen konnte gezeigt werden, dass NO tatsächlich funktionell essentiell in der IFN-gamma abhängigen Selbstlimitation der Th1-vermittelten Entzündungsreaktion war. Weitere Charakterisierung der iNOS-exprimierenden Zellen mittels FACS-Analyse ergab, dass iNOS-produzierende Zellen den Oberflächenmarker CD11b exprimierten. Diese iNOS-produzierenden Zellen waren fast ausschließlich am Ort der Entzündung zu finden. Die funktionelle in vitro Charakterisierung dieser Zellen nach ex vivo Isolierung ergab, dass diese Zellen die Proliferation von CD4+ T-Zellen supprimierten und deshalb als Myeloide-Suppressor-Zellen bezeichnet werden können. Der hier untersuchte IFN-gamma vermittelte Regulationsmechanismus scheint auf andere T-Zell-Systeme übertragbar zu sein, da IFN-gamma Blockade in einer durch CD8+ Effektor-T-Zellen vermittelten Entzündung auch zu einer Verlängerung der Entzündung führte. Zusammenfassend konnte gezeigt werden, dass das Zytokin IFN-gamma während der Effektorphase einer Immunreaktion wichtig für die Selbstlimitation ist. / The aim of the work was to understand the role of the cytokine IFN-gamma in a Th1 dependent inflammation. Starting point was the observation that the blockade of IFN-gamma, which is generally regarded as a proinflammatory cytokine, led to a more severe inflammation. We were therefore aiming at a better understanding of the mechanism of regulation, the identification of important cell types and downstream effector molecules. With the help of bone marrow chimeras we could show that the host cell which recognises IFN-gamma is of haematopoietic origin. For further understanding we compared animals under IFN-gamma neutralisation with control animals. Immunohistochemical staining revealed a strong expression of the enzyme iNOS in control animals whereas iNOS was merely detectable under IFN-gamma neutralisation. With the help of iNOS deficient animals we could show, that NO is indeed essential as downstream effector molecule. Further characterisation via FACS analysis showed that iNOS production was only observed among CD11b+ cells, roughly half of the iNOS expressing cells were also positive for GR-1. iNOS expression could only be detected at the site of inflammation. Functional in vitro characterisation of these cells after ex vivo isolation revealed that they suppressed the proliferation of CD4+ T cells. They can therefore be regarded as myeloid suppressor cells. To study whether the observed mechanisms of regulation are of any general importance, we looked at a DTH response mediated by CD8+ effector T cells and indeed we could observe a more severe inflammation under IFN-gamma neutralisation, although the effect was not quite as strong as in the Th1 mediated inflammation. In summary we could show, that the cytokine IFN-gamma is important in the limitation of the effector phase of an ongoing immune response.
30

Pollution de type urbaine au monoxyde de carbone et sensibilité du myocarde au syndrome d’ischémie-reperfusion : rôle cardioprotecteur de l’exercice / Simulated urban carbon monoxide air pollution and rat heart ischemia-reperfusion injury : cardioprotective effects of exercise

Meyer, Grégory 21 October 2010 (has links)
Diverses études épidémiologiques ont mis en évidence une relation étroite entre pollution urbaine au monoxyde de carbone (CO) et mortalité cardiovasculaire. Récemment il a été mis en évidence, chez le rat, qu'une exposition prolongée à ce polluant urbain avait pour conséquence le développement d'un phénotype cellulaire pathologique, pouvant influencer la vulnérabilité du coeur à un stress aigu. L'objectif de nos travaux était donc i) d'évaluer l'impact de la pollution au CO, sur la sensibilité du myocarde de rats au syndrome d'ischémie-reperfusion (IR) ; et ii) d'évaluer les effets potentiellement cardioprotecteurs d'un exercice pratiqué régulièrement à intensité modérée, sur le remodelage phénotypique cellulaire myocardique. Pour cela, 187 rats Wistar ont été séparés en 3 groupes : des rats contrôles, des rats exposés pendant 4 semaines au CO (30-100 ppm), et des rats entraînés en endurance avant d'être exposés au CO. La sensibilité à l'IR était évaluée par ischémie régionale réalisée sur modèle de coeur isolé perfusé de Langendorff. La fonction et les mouvements calciques de cardiomyocytes isolés était évalués en condition basale et consécutivement à un protocole d'anoxie-réoxygénation. Les résultats de ce travail confirment l'apparition d’un phénotype pathologique chez les rats exposés de façon prolongée au CO. Ce phénotype pathologique caractérisé dans notre travail par une altération de l’homéostasie calcique et du statut redox cellulaire ainsi qu'une expression tissulaire de iNOS apparait comme à l'origine de la plus grande vulnérabilité du coeur à un stress d’IR. Un autre résultat majeur de ce travail est qu’une stratégie de cardioprotection par un exercice d'intensité modérée pratiqué de manière régulière, permet de prévenir le remodelage pathologique cardiomyocytaire et ainsi l'augmentation de la sensibilité du myocarde à l'IR / Epidemiological studies suggested that carbon monoxide (CO) urban air pollution is mainly related to cardiovascular mortality. In addition, recent experimental studies have highlighted that CO exposure was responsible for the development of cardiomyocytes’ pathological remodeling, which can render the heart more vulnerable to acute stresses. Therefore, the aim of this experimental work was to i) evaluate the impact of prolonged exposure to simulated CO urban pollution on the sensitivity of the myocardium to IR ; and ii) evaluate potential cardioprotective effects of regular bouts of endurance training in this model. 187 Wistar rats were separated into 3 groups : control rats, CO rats exposed during 4 weeks to CO (30-100 ppm), and CO exercised rats. Myocardial sensibility to IR was evaluated with a regional ischemia performed on a Langendorff model of isolated heart. Moreover, the cardiomyocytes’ function and calcium handling were evaluated at basal conditions, following a protocol of cellular anoxia and reoxygenation. The results of this study confirm that chronic exposure to CO is responsible for cardiac phenotypic changes, which are characterized in this work by an imbalance in the cardiomyocytes’ oxidative status, an impairment of calcium handling and iNOS expression. These phenotypic changes were associated in this work with higher heart vulnerability to IR. Another major result of this study is that regular bouts of endurance training conducted prior to CO exposure prevented the pathological cardiac remodeling, consequently leading to higher heart vulnerability due to IR

Page generated in 0.0635 seconds